⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL301443 | 0.88 | — | — | |
| SCHEMBL323407 | 0.72 | — | — | |
| SCHEMBL9632323 | 0.72 | — | — | |
| SCHEMBL1072350 | 0.72 | — | — | |
| SCHEMBL5838 | 0.72 | — | — | |
| SCHEMBL7195737 | 0.72 | — | — | |
| SCHEMBL3247394 | 0.72 | — | — | |
| SCHEMBL3148506 | 0.72 | — | — | |
| SCHEMBL633464 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL22661008 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0929293-B1 | LIPOSOMES CONTAINING A CISPLATIN COMPOUND | SEQUUS PHARM INC (US) | 2003-10-22 | — | — | EP | disclosed |
| US-6126966-A | LIOSOMES WITH ENTRAINMENT OF CISPLATIN COMPOUNDS | SEQUUS PHARMACEUTICALS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-5945122-A | A LIPOSOME CONTAINING AN ENTRAPPED CISPLATIN COMPOUND HAVING A SURFACE COATING OF HYDROPHILILC POLYMER CHAINS ON INNER AND OUTER SURFACES; ANTITUMOR AND ANTICARCINOGENIC AGENT | SEQUUS PHARMACEUTICALS, INC. (US) | 1999-08-31 | — | — | US | disclosed |
| EP-0929293-A1 | LIPOSOMES CONTAINING A CISPLATIN COMPOUND | SEQUUS PHARMACEUTICALS, INC. (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998007409-A1 | LIPOSOMES CONTAINING A CISPLATIN COMPOUND | SEQUUS PHARMACEUTICALS, INC. (US) | 1998-02-26 | — | — | WO | disclosed |